Compounds > fusidic acid
Page last updated: 2024-09-04

fusidic acid and Acinetobacter Infections

fusidic acid has been researched along with Acinetobacter Infections in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barrett, J; Kloprogge, F; Morris, R; Phee, LM; Standing, JF; Wareham, DW1
Betts, JW; Bharathan, B; Phee, LM; Wareham, DW1
Bowler, SL; Doi, Y; McElheny, CL; Mettus, RT; Spychala, CN1
Cong, Y; Fan, B; Guan, J; Wang, X1
Dudzevicius, V; Sakalauskas, R; Vitkauskiene, A1

Other Studies

5 other study(ies) available for fusidic acid and Acinetobacter Infections

ArticleYear
Pharmacokinetic-pharmacodynamic modelling to investigate in vitro synergy between colistin and fusidic acid against MDR Acinetobacter baumannii.
    The Journal of antimicrobial chemotherapy, 2019, 04-01, Volume: 74, Issue:4

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Colistin; Drug Synergism; Fusidic Acid; Humans; Microbial Viability; Models, Theoretical

2019
Colistin and Fusidic Acid, a Novel Potent Synergistic Combination for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:8

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Fusidic Acid; Humans; Microbial Sensitivity Tests

2015
In Vitro Activity of Fusidic Acid-Containing Combinations against Carbapenem-Resistant Acinetobacter baumannii Clinical Strains.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:8

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Fusidic Acid; Humans; Microbial Sensitivity Tests

2016
Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model.
    PloS one, 2016, Volume: 11, Issue:6

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Colistin; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Fosfomycin; Fusidic Acid; Meropenem; Mice; Microbial Sensitivity Tests; Minocycline; Rifampin; Sulbactam; Thienamycins; Tigecycline

2016
[The impact of antibiotic use on hospital-acquired pneumonia: data of etiology tests].
    Medicina (Kaunas, Lithuania), 2003, Volume: 39, Issue:3

    Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bronchoalveolar Lavage Fluid; Ceftazidime; Cefuroxime; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fusidic Acid; Gentamicins; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Penicillins; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Staphylococcus aureus; Sulbactam; Vancomycin Resistance

2003